Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00625456
Recruitment Status : Completed
First Posted : February 28, 2008
Last Update Posted : December 3, 2015
Sponsor:
Information provided by (Responsible Party):
SillaJen, Inc. ( Jennerex Biotherapeutics )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2010
  Actual Study Completion Date : June 2014